News

The biosimilar is manufactured by JHL’s Taiwanese subsidiary. It is the first company from the Greater China to secure European approval for clinical trial of a monoclonal antibody

Merck received a complete response letter from the agency. The company said it will review the letter and determine its next steps. The applications were based on the

The drug also improved erythroid response, an important measure of the formation of new red blood cells. The company said data from the phase 3 Arcade study was

Amounts, unless specified otherwise, are expressed in United States dollars and in accordance with International Financial Reporting Standards ("IFRS"). First Quarter Highlights and Corporate Update Enrollment of First

The lots are being recalled as a precautionary measure because of a potential risk of inconsistencies in dosing of the product. "Clumps" of ibuprofen may form in the

The global health community is urging caution and care in response to Zika’s explosive spread and is calling for rapidly stepped up efforts by researchers to find therapeutics

Cormorant Asset Management, Hillhouse Capital Group and venBio Global Strategic Fund led the Series D preferred-stock financing. Existing investors Morningside Venture Investments, AJU IB Investment, and Epidarex Capital

The UK High Court decided that the Alimta vitamin regimen patent would not currently be infringed by Actavis marketing pemetrexed trometamol in the UK, France, Italy and Spain

The companies did not disclose the financial terms of the transaction. Pfizer will retain commercialization and manufacturing rights to infliximab in all countries outside the EEA. Sandoz aims